#BIO2022 is back in person - San Diego June 13-16. Join us for limitless possibilities at the largest gathering of the #biotech industry. bio.org/events/bio-int…

Our general partner, Paul Burton together with Mukesh Kumar, PhD, RAC, the President/Chairman of Akan Biosciences and Kettil Cedercreutz,PhD, CEO of Temprian Therapeutics Therapeutics, will be attending the Bio Conference in-person in June! See you there. #biotech #biotech #startup

We are seeing progress in Chicago's desirability & perception as a tech hub. The Net Promoter Score (NPS) study P33 ran in 2018 gave Chicago a score of -52%. Today, Chicago's NPS score is -11. Still much work to be done, but the progress is encouraging. ➡️p33chicago.com/npsreport2022/

Good Day BIO Live from San Diego – Wednesday, June 15, 2022 x.com/i/broadcasts/1…

There is a new Canadian research trial looking at patients suffering from post-COVID syndrome — a study that has identified a potential key culprit causing some people to continue experiencing breathing issues months after contracting COVID-19. globalnews.ca/news/8950820/l…

How our team from 2Flo Ventures, Temprian Therapeutics & Akan Biosciences showed up at the Bio Conference mid last month. We're thankful we created new networks & reconnected with old friends. Biotechnology Innovation Organization Paul Burton #bio2022 #Biotechnology #dermatology #RegenerativeMedicine

Are you suffering from chronic disease and/or pain? 4D Healthware wants to make a difference! Wondering what we do and how it all works? If you cannot visit a health system for any reason, ask your clinic about 4dhealthware.com #healthcare #DigitalHealthcare #FQHC #clinic

Dedmon had a #BRCA2 mutation. Her personalized cancer prevention plan included a prophylactic double mastectomy. At CancerIQ, we work with breast centers to implement & scale high-risk programs, ensuring no patients like her are missed. #BCSM #GeneChat bit.ly/3NLnmVT

Only 5 days left to apply for Wintrust Business Spotlight pitch competition for female & minority-owned businesses! Apply for your chance to showcase your company to local business leaders & investors, & throw out the first pitch Chicago Cubs game! Apply here: bit.ly/3Ix1LiU

#2FloEquity News: Join us in welcoming Dr. Modestus Obochi, PhD MBA to the 2Flo advisory committee and the board of directors at Temprian Therapeutics, one of 2Flo’s portfolio companies! Paul Burton #healthequity #biotech #vitiligo #Blackleaders #venturecapital #startup

We at 2Flo are proud to be associated with 4D Healthware and its very able team including Angela Littrell. #2FloEquityNews #venturecapital #startup #Chicago Paul Burton Star Cunningham

As an #earlystage #Chicago #healthcare investor & #startup studio, Paul & Team 2Flo Ventures are deeply invested in their social mission, hands-on development approach, identifying opportunities for growth, & expanding access to the healthcare #innovation ecosystem 👏

#2FloEquityNews: we're so excited that Paul Burton's & Sharon Ray's insightful article on inclusive health investments has been published by FierceBiotech FiercePharma. fiercehealthcare.com/health-tech/in… #inclusion #healthequity #venturecapital #startup #Chicago #venturecapital

“Equitable healthcare funding is the true foundation for health equity.” ⁦Paul Burton⁩ ⁦Sharon Ray⁩ ⁦2Flo Ventures⁩ ⁦FierceHealthcare⁩ ⁦Paige Minemyer⁩ #2floequity #startup #venturecapital #healthequity fiercehealthcare.com/health-tech/in…

Congratulations to 2Flo Ventures for doing the work. #chicago #lifesciences #inclusiveventures

Please enjoy this FierceHealthcare article that discusses inclusive health investment. 2Flo Ventures has selected companies like 4D Healthware making an actual, real difference in moving the needle on health equity. #venturecapital #virtualhealthcare bitly.ws/vQ4e

#2FloEquity News: There is hope in the fight against #sepsis - Vivacelle Bio has reached the halfway point of the Phase IIa clinical trial investigating the potential of its nanoparticle technology to treat hypovolemia. Read Vivacelle’s press release here: lnkd.in/g69ranUC